Xtant Medical Holdings, Inc.
XTNT · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.1% | 7.6% | 4.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 66.1% | 68.6% | 61.5% | 50.8% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 10.9% | 16.9% | 6.5% | -2.7% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 3.9% | 10% | 0.2% | -10% |
| EPS Diluted | 0.009 | 0.024 | 0 | -0.023 |
| % Growth | -63.2% | 5,875% | 101.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |